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Abstract
Background: Psychotropic drugs are commonly utilised among the elderly. This study aimed to analyse whether two 
socioeconomic determinants - income and marital status - are associated with differences in utilisation of psychotropic 
drugs and potentially inappropriate psychotropic drugs among elderly in Sweden.
Methods: All individuals aged 75 years and older who had purchased a psychotropic drug in Sweden during 2006 
were included (68.7% women, n = 384712). Data was collected from national individual-based registers. Outcome 
measures were utilisation of three or more psychotropic drugs and utilisation of potentially inappropriate psychotropic 
drugs, as classified by the Swedish National Board of Health and Welfare.
Results: Individuals with low income were more likely to utilise three or more psychotropic drugs compared to those 
with high income; adjusted odds ratio (aOR) 1.12 (95% confidence interval [CI] 1.10-1.14). The non-married had a 
higher probability for utilising three or more psychotropic drugs compared to the married (aOR 1.22; CI 1.20-1.25). The 
highest probability was observed among the divorced and the never married. Potentially inappropriate psychotropic 
drugs were more common among individuals with low compared to high income (aOR 1.14; CI 1.13-1.16). Compared 
to the married, potentially inappropriate psychotropic drug utilisation occurred more commonly among the non-
married (aOR 1.08; CI 1.06-1.10). The never married and the divorced had the highest probability.
Conclusions: There was an association between socioeconomic determinants and psychotropic drug utilisation. The 
probability for utilising potentially inappropriate psychotropics was higher among individuals with low income and 
among the non-married.
Background
Psychotropic drugs are common among the elderly and
represent a considerable proportion of inappropriate
drugs used in this population [1]. The elderly are espe-
cially vulnerable to drug-related adverse health out-
comes, and exposure to inappropriate drugs is associated
with an increased risk of such events [2]. Socioeconomic
determinants (e.g., poverty and lack of social support)
influence health. Low socioeconomic status is associated
with a higher prevalence of overall morbidity, including
psychiatric morbidity [3-5], but also a decreased access to
high-quality care and a lower consumer demand [6,7].
Further, marital status and social support is associated
with health and health behaviour [8-10].
Health care quality differs between socioeconomic
groups, particularly regarding the extent of preventive
care, the cost of treatment procedures, and appropriate
drug utilisation [6,11-13]. However, research focusing on
the association between socioeconomic determinants,
psychotropic drugs, and potentially inappropriate psy-
chotropic drugs among the elderly is scarce [1,14].
Explicit criteria on potentially inappropriate drugs
among the elderly often focus on pharmacological appro-
priateness, such as choice of drug, dose, drug interac-
tions, duplications, and duration of drug therapy [15].
The Swedish National Board of Health and Welfare
(NBHW) has published a list of quality indicators and
explicit criteria for measuring inappropriate drug utilisa-
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tion among the elderly in Sweden [16]. The list is based
on Swedish recommendations, expert opinions, and
internationally published explicit criteria such as Beers'
criteria [17].
The introduction of the Swedish Prescribed Drug Reg-
ister in 2005 [18] enabled linkage of information on drug
utilisation and social determinants on an individual level
with complete national coverage. This study aimed to
analyse whether two socioeconomic determinants -
income and marital status - are associated with differ-
ences in utilisation of psychotropic drugs and potentially
inappropriate psychotropic drugs (PIP) among the elderly
in Sweden.
Methods
Study participants and data sources
The study participants encompassed all individuals aged
75 years and older on 1 January 2006 in Sweden who had
purchased a prescribed psychotropic drug in 2006 (n =
384712). Data on dispensed prescription drugs was
obtained from the national individual-based Swedish Pre-
s c r i b e d  D r u g  R e g i s t e r  h e l d  a t  t h e  N a t i o n a l  B o a r d  o f
Health and Welfare [18]. The register includes all pre-
scribed drugs purchased at Swedish pharmacies, but not
drugs utilised in hospitals or purchased over the counter.
Information on the participants' age, sex and all pur-
chased prescription drugs (type, amount and date of pur-
chase) was collected. In Sweden, co-payment for
reimbursed drugs is independent of income. The maxi-
mum co-payment for prescription drugs within the phar-
maceutical benefits scheme is SEK 1800 (SEK 1 = n0.106
on 1 January 2006) per twelve month period (Act
2002:160 on Pharmaceutical Benefits, etc.). Data from the
Swedish Prescribed Drug Register was linked to the LISA
database (the longitudinal integration database for health
insurance and labour market studies; held at Statistics
Sweden) via the unique person identification number.
Information regarding family disposable income, number
of family members, marital status, country of birth and
date of death and migration was collected from the LISA
database. The project was approved by the regional ethics
board in Gothenburg, Sweden (No. 054-07).
Drugs were classified according to the Anatomical
Therapeutic Chemical (ATC) classification system [19].
Psychotropic drugs were categorised as follows: any psy-
chotropic (ATC-codes N05 and N06), antipsychotics
(N05A), anxiolytics (N05B), hypnotics (N05C), and anti-
depressants (N06A).
Socioeconomic determinants
Income was calculated using the square root scale (i.e.,
family disposable income during 2005 divided by the
square root of the number of family members) [20,21].
The study participants were categorised into income ter-
tiles to focus on any differences between those with the
lowest income compared to those with the highest
income. For analyses stratified by sex, this categorisation
was performed separately for men and women. Marital
status on 31 December 2006 was categorised as married,
never married, divorced, or widowed. Country of birth
was included as a potential confounder and categorised
as Sweden, other Nordic countries, other European coun-
tries, and outside Europe. The number of unique nonpsy-
chotropic drug substances purchased during the study
period was used as a proxy for health care utilisation and
comorbidity [22].
Outcome measures
The number of unique psychotropic drugs purchased
during 2006 was dichotomised into three or more vs. less
than three psychotropic drugs. Utilisation of three or
more psychotropic drugs was considered to reflect an
increased exposure to psychotropic drugs. PIP was
defined as the utilisation of potentially inappropriate psy-
chotropic substances (PIPS) or potentially inappropriate
combinations of psychotropics (PICP), as classified by the
NBHW [16]. PIPS was defined as at least one purchase of
long-acting benzodiazepines (flunitrazepam, nitraze-
pam, and diazepam), anticholinergic psychotropics, pro-
piomazine, or triazolam during 2006. PICP was defined
as concurrent utilisation of two or more benzodiazepines,
two or more psychotropics in the same class (e.g., two or
more hypnotics), and two or more anticholinergic psy-
chotropics for a total of 40 days during 2006. The estima-
tion of concurrent drug utilisation has been described
previously [23]. Briefly, information on prescribers' dos-
age instructions is available only as a free text section in
the register and is therefore not statistically processable.
A review of prescribed daily doses (PDDs) was performed
for a random sample of dispensed prescriptions for each
substance. Substance-specific population average PDDs
were estimated for each psychotropic substance, thus
enabling the calculation of theoretical treatment periods
based on date of purchase and purchased amount. A
detailed description of PIP and associated prevalence
rates have been reported previously [23].
Statistical analyses
A person-year proportion, defined as the proportion of
days resident in the country and alive during 2006, was
calculated for each individual. For example, the person-
year proportion for an individual who died on 26 March
2006 was 0.23 (84/365 days). The person-year proportion
was included in the regression models, thereby taking
date of death or migration into account. Further, the sum
of the person-year proportions was used as the denomi-
nator when calculating the prevalence of utilisation ofLesén et al. BMC Public Health 2010, 10:118
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three or more psychotropic drugs and of PIP among the
study participants.
Simple and multiple logistic regression analyses were
performed for the outcome measures of three or more
psychotropic drugs and PIP. The multiple logistic regres-
sion models included income or marital status, age, sex,
c o u n t r y  o f  b i r t h ,  n u m b e r  o f  u n i q u e  n o n p s y c h o t r o p i c
drug substances purchased during the study period, and
the person-year proportion (not included in analyses on
marital status). All regression analyses were also per-
formed stratified by age and sex. Due to partially missing
data, 366 individuals were excluded from the regression
analyses including income. Marital status was recorded at
the end of 2006 and was therefore missing for the 40880
individuals who died and the 77 who migrated during the
study period. Further, the regression analyses were
repeated in a 10% random sample, since the risk of false
positive results increases as the sample size increases.
Simple and multiple Poisson regression analyses were
performed for count outcomes (number of psychotropic
drugs and number of PIP). The results from the Poisson
regression analyses were in agreement with the logistic
regression analyses, and are therefore not presented. Chi-
square tests were used to compare proportions. The level
for statistical significance was 0.05. SAS version 9.1.3
(SAS Institute, NC) was used for data management, and
Stata version 10.1 (StataCorp, TX) was used for statistical
analyses.
Results
Table 1 includes the characteristics of the study partici-
pants. Individuals with low income had n12003 or less,
and those with high income had n15171 or more. Among
those who purchased psychotropic drugs, median
income was n14937 for men and n12620 for women. In
the entire Swedish population aged 75 years and older (n
= 800129), median income was n17352 for men and
n13546 for women (source: Statistics Sweden). The pro-
portion of married individuals was lower among psycho-
tropic drug users than in the corresponding entire
Swedish population (men 60.8% [189616/311796],
women 27.5% [133955/487305]; source: Statistics Swe-
den).
Among the study participants aged 75-79 years, 22.5%
(25828/114401) had low income; among individuals aged
85 years and older, the corresponding proportion was
43.7% (65422/149682). Death or migration occurred
more commonly among individuals aged 85 years or
older compared to 75-79 years (16.6% vs. 5.4%; p < 0.001),
among those with low compared to high income (12.9%
vs. 8.8%; p < 0.001), and among men compared to women
(13.8% [16610] vs. 9.2% [24347]; p < 0.001) (Table 1).
Among elderly psychotropic drug users, 22.1% (85182)
had purchased three or more psychotropic drugs during
2006. Individuals who died or migrated during the study
period were more likely to utilise three or more psycho-
tropic drugs compared to those who survived and did not
migrate (31.8% [13019] vs. 21.0% [72163]; p < 0.001).
Older age, female sex, and low income were associated
with a higher probability for utilising three or more psy-
chotropic substances (Table 2).
Among individuals with low income, the adjusted odds
ratio (aOR) for utilising three or more psychotropic drugs
was 1.34 (95% confidence interval [CI] 1.26-1.43; refer-
ence: high income) for men aged 75-79 years, and 0.99
(CI 0.93-1.05) among men aged 85 years or more. For
women, the corresponding aORs were 1.23 (CI 1.17-1.28)
in the younger age group and 1.03 (CI 0.99-1.07) in the
older age group.
Compared to married individuals, the never married,
the divorced and the widows/widowers showed a higher
probability for utilising three or more psychotropic drugs
(Table 3). Men who were never married and divorced
women showed the highest probability for utilising three
or more psychotropic drugs. The associations were more
pronounced among younger rather than older elderly
(data not shown).
PIPS were utilised by 36.0% (138467), and PICP by
12.2% (46746); 9.0% (34596) utilised PIPS as well as PICP.
Thus, PIP were utilised by 39.2% (150617). PIP utilisation
occurred more commonly among those who died or
migrated during the study period compared to those who
survived and did not migrate (42.2% [17274] vs. 38.8%
[133343]; p < 0.001, respectively). Older age and female
sex were inversely associated with PIP utilisation, while
low income was associated with a higher probability for
PIP utilisation (Table 4). The probability for utilising PIPS
and PICP, respectively, was higher among individuals
with low income (PIPS: aOR 1.14; CI 1.12-1.16; PICP:
aOR 1.11; CI 1.08-1.14; reference: high income). The aOR
for having both PIPS and PICP was 1.12 (1.09-1.15)
among individuals with low income compared to those
with high income.
The aOR among men with low income was 1.23 (95%
CI 1.17-1.30; reference: high income) in the younger age
group, and 1.14 (1.08-1.20) in the older age group. For
women, the corresponding aORs were 1.13 (1.09-1.18)
and 1.09 (1.05-1.12), respectively.
Never married and divorced individuals were more
likely to utilise PIP compared to married individuals
(Table 5). The probability for PIP utilisation was margin-
ally higher among widows/widowers. These associations
were more pronounced among the younger than the
older elderly (data not shown). The aOR for having both
PIPS and PICP was 1.51 (1.44-1.59) among the never
married, 1.41 (1.36-1.47) among the divorced, and 1.14
(1.11-1.18) among the widows/widowers, as compared to
the married.Lesén et al. BMC Public Health 2010, 10:118
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The regression analyses performed in the 10% random
sample gave similar results as the original analyses, with
two exceptions. The middle income group and the wid-
ows/widowers did not have a statistically significant
higher probability for utilisation of PIP in the adjusted
analyses (p = 0.08 and p = 0.66, respectively).
Table 1: Characteristics of the study participants.
Men (n = 120426) Women (n = 264286) Total (n = 384712) Death/migration, No. 
(Row %)
Age
75-79 years, No. 
(%)
39636 (32.9) 74932 (28.4) 114568 (29.8) 6128 (5.4)
80-84 years, No. 
(%)
39728 (33.0) 80645 (30.5) 120373 (31.3) 9931 (8.3)
85+ years, No. (%) 41062 (34.1) 108709 (41.1) 149771 (38.9) 24898 (16.6)
Missing, No. (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Income (n)*
High income, 
median (%)
21215 (33.0) 17457 (33.0) 18743 (33.0) 11106 (8.8)
Middle income, 
median (%)
14937 (33.8) 12620 (33.9) 13126 (33.9) 13438 (10.3)
Low income, 
median (%)
11748 (33.1) 10281 (33.0) 10632 (33.1) 16401 (12.9)
Missing, No. (%) 188 (0.2) 177 (0.1) 365 (0.1) 12 (3.3)
Marital status
Married, No. (%) 58376 (48.5) 58395 (22.1) 116772 (30.4) -
Never married, No. 
(%)
8400 (7.0) 13350 (5.1) 21750 (5.7) -
Divorced, No. (%) 10100 (8.4) 25646 (9.7) 35746 (9.3) -
Widowed, No. (%) 26814 (22.3) 142448 (53.9) 169262 (44.0) -
Missing, No. (%)† 16736 (13.9) 24446 (9.2) 41182 (10.7) 40957 (99.5)
Country of birth
Sweden, No. (%) 111738 (92.8) 241804 (91.5) 353542 (91.9) 38151 (10.8)
Other Nordic 
countries, No. (%)
3918 (3.3) 11852 (4.5) 15770 (4.1) 1429 (9.1)
Europe, No. (%) 3616 (3.0) 8232 (3.1) 11848 (3.1) 1067 (9.0)
Outside Europe, 
No. (%)
1130 (0.9) 2365 (0.9) 3495 (0.9) 310 (8.9)
Missing, No. (%) 24 (0.0) 33 (0.0) 57 (0.0) 0 (0.0)
Number of unique 
drugs
1-4, No. (%) 12219 (10.1) 26479 (10.0) 38698 (10.1) 2489 (6.4)
5-9, No. (%) 41504 (34.5) 91856 (34.8) 133360 (34.7) 12040 (9.0)
10+, No. (%) 66703 (55.4) 145951 (55.2) 212654 (55.3) 26428 (12.4)
Missing, No. (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
* Family disposable income for year 2005, adjusted for family size. SEK 1 = n0.106 (1 January 2006).
† Marital status was missing for all individuals who died or migrated during 2006 (n = 40957). When these were excluded, marital status was 
missing for 225 individuals.Lesén et al. BMC Public Health 2010, 10:118
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Discussion
The present study showed a higher likelihood for utilising
several psychotropics as well as PIP among individuals
with low income and among the non-married. While the
magnitudes of the higher probabilities were fairly small,
they still indicate that socioeconomic determinants are
associated with differences in utilisation of psychotropic
drugs among the elderly. The magnitudes are comparable
to a previous Swedish study on inappropriate drug use
and education level among elderly [13]. These findings
could suggest structural problems in the health care sys-
tem.
Individuals with low income and the non-married were
more likely to utilise three or more psychotropic drugs
compared to those with high income and married indi-
viduals, respectively. Previous research has shown that
the more vulnerable groups have an increased morbidity
[4,5]. Information on morbidity was not available for this
study; however, our findings could correspond to the
ambition of the Swedish health care system to provide
health care in relation to individual needs [24].
One of the cornerstones of the Swedish health care is
that good health care should be provided for the entire
population on equal terms [24]. Consequently, quality in
drug treatment should not differ between socioeconomic
groups. In this study, individuals with low income were
more likely to utilise psychotropic drugs classified as
potentially inappropriate by the NBHW compared to
those with high income. These findings are consistent
with previous studies on socioeconomic determinants
and drug utilisation in Sweden [13] and in other countries
[11,25-27]. Physicians' choice of drug may be influenced
by patients' requests [28]. Since individuals in higher
socioeconomic groups generally have increased access to
health and drug information [6], they may be more likely
to request drugs with a more favourable risk-benefit pro-
file. Previous research has shown that individuals in
higher socioeconomic groups are more likely to utilise
newly marketed and brand-name drugs [26,29].
Table 2: Age, sex and income and utilisation of three or more psychotropic drugs among the study participants 
(n = 384346).
Utilisation of 
three or more 
psychotropics, 
No./Total N (%)†
Odds Ratio 
(95% CI)‡
p-value Adjusted Odds 
Ratio (95% CI)§
p-value
Age
75-79 22729/111787 
(20.3)
1 (Reference) 1 (Reference)
80-84 26227/115802 
(22.7)
1.12 (1.09-1.14) < 0.001 1.09 (1.07-1.11) < 0.001
85+ 36226/137798 
(26.3)
1.25 (1.22-1.27) < 0.001 1.19 (1.16-1.21) < 0.001
Sex
Men 24671/112602 
(21.9)
1 (Reference) 1 (Reference)
Women 60511/252786 
(23.9)
1.17 (1.15-1.19) < 0.001 1.14 (1.12-1.16) < 0.001
Income*
High 25959/121784 
(21.3)
1 (Reference) 1 (Reference)
Middle 29087/124009 
(23.5)
1.11 (1.09-1.13) < 0.001 1.06 (1.04-1.08) < 0.001
Low 30075/119233 
(25.2)
1.19 (1.17-1.21) < 0.001 1.12 (1.10-1.14) < 0.001
* Family disposable income for year 2005, adjusted for family size.
† The denominator was adjusted according to the proportion of days the population was resident in the country and alive during 2006
‡ Adjusted for the proportion of days resident in the country and alive during 2006
§ Adjusted for age, sex, income, country of birth, proportion of days resident in the country and alive during 2006, and number of unique 
nonpsychotropic drug substances purchased during the study period.Lesén et al. BMC Public Health 2010, 10:118
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Marriage is positively associated with health and health
behaviour [8-10]. In a somewhat younger population,
divorced women and widowed men had an increased
utilisation of psychotropic drugs compared to married or
single men and women [14]. Married individuals in our
study were less likely to utilise three or more psychotro-
pic drugs as well as PIP compared to non-married indi-
viduals. Previous research on the utilisation of potentially
inappropriate drugs and marital status or cohabitation is
scarce and inconclusive [11,30]. The associations
between marital status and drug utilisation in this popu-
lation were more pronounced among men than among
women, which may be related to the higher health bene-
fits gained from marriage among men than among
women [9,31].
Compared to women, men were less likely to utilise
three or more psychotropic substances, but more likely to
utilise PIP. Previous research showed that men were less
likely to utilise antidepressants, but more likely to utilise a
potentially inappropriate antidepressant [27]. Women
generally are more knowledgeable than men about health
issues, and physicians describe women as more demand-
ing [32]. This characteristic could increase women's
demands regarding quality of care. Further, the oldest old
were more likely to utilise several psychotropic drugs, but
less likely to utilise PIP as compared the younger elderly.
The oldest old may have been prescribed these drugs for
a long time and may be unwilling to change to newer
drugs. Also, physicians may be more cautious in prescrib-
ing these drugs to the oldest old due to the increased risk
of adverse events.
Individuals who died during the study period were
more likely to utilise three or more psychotropics as well
as PIP. This finding could indicate that these individuals
had poorer health than the survivors, or that utilisation of
these drugs might increase the risk for mortality. How-
ever, it is not possible to make any such conclusions
based on the data available for this study.
The main strength of this study is its population-based
design using national individual-based register data.
However, our data does not include drugs utilised in hos-
pitals. The most severe cases may therefore be omitted
from the study population, although it is unlikely that
individuals are hospitalised during periods long enough
Table 3: Marital status and utilisation of three or more psychotropic drugs among the study participants (n = 343530)*.
Utilisation of 
three or more 
psychotropics, 
No. (%)
Odds Ratio 
(95% CI)
p-value Adjusted Odds 
Ratio (95% CI) †
p-value
Total (n = 
343530)
Married 21238 (18.2) 1 (Reference) 1 (Reference)
Never married 5028 (23.1) 1.35 (1.31-1.40) < 0.001 1.35 (1.30-1.40) < 0.001
Divorced 8546 (23.9) 1.41 (1.37-1.45) < 0.001 1.35 (1.31-1.39) < 0.001
Widow/widower 37332 (22.1) 1.27 (1.25-1.30) < 0.001 1.17 (1.14-1.19) < 0.001
Men (n = 
103690)
Married 10119 (17.3) 1 (Reference) 1 (Reference)
Never married 1897 (22.6) 1.39 (1.32-1.47) < 0.001 1.45 (1.37-1.54) < 0.001
Divorced 2165 (21.4) 1.30 (1.24-1.37) < 0.001 1.32 (1.25-1.39) < 0.001
Widow/widower 5489 (20.5) 1.23 (1.18-1.27) < 0.001 1.19 (1.15-1.24) < 0.001
Women (n = 
239840)
Married 11119 (19.0) 1 (Reference) 1 (Reference)
Never married 3131 (23.5) 1.30 (1.25-1.36) < 0.001 1.28 (1.23-1.34) < 0.001
Divorced 6381 (24.9) 1.41 (1.34-1.46) < 0.001 1.35 (1.30-1.40) < 0.001
Widow/widower 31843 (22.4) 1.22 (1.19-1.25) < 0.001 1.15 (1.12-1.18) < 0.001
† Adjusted for age, sex, country of birth, and number of unique nonpsychotropic drug substances purchased during the study period
* Individuals who died or migrated during 2006 were excluded due to missing information on marital statusLesén et al. BMC Public Health 2010, 10:118
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to avoid purchase of drugs in pharmacies, as the study
period was one year. Further, no information on the
actual use of drugs or indication was available. The cross-
sectional design precludes any conclusions regarding
causality. Marital status was recorded at the end of the
study period; consequently, this information was missing
for individuals who died or migrated during the study
period. Those individuals were excluded from the regres-
sion analyses on marital status and PIP. Since marriage
can be related to an increased survival [33], the associa-
tion between marital status and PIP may be underesti-
mated. Further, large sample sizes may increase the risk of
false positive results. However, the regression analyses
performed in the 10% random sample gave similar results
as the original analyses.
Cost-related primary nonadherence is associated with
income [34]. The Swedish Prescribed Drug Register
includes purchased drugs only. Consequently, individuals
who choose not to redeem their prescriptions, because
they cannot afford them or for other reasons, are not
present among the study participants. The restriction of
the study participants to those with at least one purchase
of a prescribed psychotropic drug may thus underesti-
mate the relationship between income level and drug util-
isation.
The classification of PIP was based on international
explicit criteria such as Beers' criteria, adapted to Swed-
ish conditions. The scientific documentation is substan-
tial regarding the use of explicit criteria [2]. In some
cases, however, drugs classified as potentially inappropri-
ate may have been appropriately prescribed. This could
not be determined, as the Swedish Prescribed Drug Reg-
ister does not include the necessary information.
Conclusions
The probability for utilising potentially inappropriate
psychotropics, as classified by the NBHW, was higher
among individuals with low income and among the non-
married. These findings indicate that socioeconomic dif-
Table 4: Age, sex, and income and utilisation of potentially inappropriate psychotropics among the study participants 
(n = 384346).
PIP, No./Total N 
(%)†
Odds Ratio 
(95% CI)‡
p-value Adjusted Odds 
Ratio (95% CI)§
p-value
Age
75-79 45788/111787 
(41.0)
1 (Reference) 1 (Reference)
80-84 46658/115802 
(40.3)
0.95 (0.93-0.96) < 0.001 0.93 (0.91-0.94) < 0.001
85+ 58171/137798 
(42.2)
0.95 (0.93-0.96) < 0.001 0.91 (0.90-0.93) < 0.001
Sex
Men 47997/112602 
(42.6)
1 (Reference) 1 (Reference)
Women 102620/252786 
(40.6)
0.96 (0.95-0.97) < 0.001 0.94 (0.93-0.95) < 0.001
Income*
High 48027/121784 
(39.4)
1 (Reference) 1 (Reference)
Middle 51491/124009 
(41.5)
1.07 (1.06-1.09) < 0.001 1.08 (1.07-1.10) < 0.001
Low 50983/119233 
(42.8)
1.10 (1.08-1.12) < 0.001 1.14 (1.13-1.16) < 0.001
PIP: Potentially inappropriate psychotropic drugs
* Family disposable income for year 2005, adjusted for family size.
† The denominator was adjusted for the proportion of days the population was resident in the country and alive during 2006
‡ Adjusted for the proportion of days resident in the country and alive during 2006
§Adjusted for age, sex, income, country of birth, proportion of days resident in the country and alive during 2006, and number of unique 
nonpsychotropic drug substances purchased during the study period.Lesén et al. BMC Public Health 2010, 10:118
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ferences appear to exist in the quality of drug utilisation
among elderly.
The differing levels of health knowledge and behaviour
among the various socioeconomic groups need to be
acknowledged in clinical practice. Efforts to increase
good communication between prescribers and patients
striving for concordance as well as patient empowerment
should be promoted [35]. Further, drug prescribing
should not be biased based on socioeconomic character-
istics of the patient. Due to the increasing number of
elderly in the population, an enhanced knowledge about
interventions that effectively increases rational drug use
and decreases the impact of socioeconomic determinants
in the quality of care among the elderly is essential.
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